ALNYLAM PHARMACEUTICALS, INC. Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31)
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) of $68.21 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Notes › Equity
us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1 · last filed 2019-10-31
- ALNYLAM PHARMACEUTICALS, INC. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2018-06-30 was $0.00.
- ALNYLAM PHARMACEUTICALS, INC. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2018-03-31 was $68.21M.
| Period end | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 3 month | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 6 month |
|---|---|---|
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $68.21M 10-Q · filed 2019-08-06 |
| 2018-03-31 | $68.21M 10-Q · filed 2019-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |